Literature DB >> 25232435

Relationship of high CH50 level and interruption of cascade reaction of complement mRNA expression in acute venous thromboembolism patients.

Siwan Wen1, Fan Yang2, Lemin Wang1, Qianglin Duan1, Zhu Gong1, Wei Lv1.   

Abstract

In patients with pulmonary embolism (PE), forepart components of complements were activated. However there are interruption/decrease of cascade reaction and cytolytic effects in complement system. This study detected CRP, CH50, C3 and C4 levels in patients with venous thromboembolism (VTE) and compare with the imbalance of complement associated gene mRNA expression in PE patients. There was significant increase of CH50 in acute VTE patients. Even though CH50 increased significantly in acute VTE patients and had a relatively high sensitivity, cytolytic effects of complements might decrease, based on the genomics results of complement cascade reactions imbalance/interruption and increased total complements in VTE patients.

Entities:  

Keywords:  CH50; complement; pulmonary embolism

Year:  2014        PMID: 25232435      PMCID: PMC4161595     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  10 in total

1.  Acute pulmonary embolism and dysfunction of CD3+ CD8+ T cell immunity.

Authors:  Lemin Wang; Haoming Song; Zhu Gong; Qianglin Duan; Aibin Liang
Journal:  Am J Respir Crit Care Med       Date:  2011-12-01       Impact factor: 21.405

2.  Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Gordon H Guyatt; Elie A Akl; Mark Crowther; David D Gutterman; Holger J Schuünemann
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Severe acute respiratory syndrome and venous thromboembolism in multiple organs.

Authors:  Yi Xiang-Hua; Wang Le-Min; Liang Ai-Bin; Gong Zhu; Lai Riquan; Zhu Xu-You; Rui Wei-Wei; Wang Ye-Nan
Journal:  Am J Respir Crit Care Med       Date:  2010-08-01       Impact factor: 21.405

4.  Compromised T-cell immunity and virus-like structure in a patient with pulmonary hypertension.

Authors:  Lemin Wang; Zhu Gong; Aibin Liang; Yuan Xie; Shu-Lin Liu; Zhang Yu; Ling Wang; Yenan Wang
Journal:  Am J Respir Crit Care Med       Date:  2010-08-01       Impact factor: 21.405

5.  Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence).

Authors: 
Journal:  Int Angiol       Date:  2006-06       Impact factor: 2.789

6.  T cell-mediated immune deficiency or compromise in patients with CTEPH.

Authors:  Song Haoming; Wang Lemin; Gong Zhu; Liang Aibin; Xie Yuan; Lv Wei; Jiang Jinfa; Xu Wenjun; Shen Yuqin
Journal:  Am J Respir Crit Care Med       Date:  2011-02-01       Impact factor: 21.405

7.  Rod-like bacteria and recurrent venous thromboembolism.

Authors:  Lemin Wang; Xiaoyu Zhang; Qianglin Duan; Wei Lv; Zhu Gong; Yuan Xie; Aibin Liang; Yenan Wang
Journal:  Am J Respir Crit Care Med       Date:  2012-10-01       Impact factor: 21.405

8.  Analysis on the pathogenesis of symptomatic pulmonary embolism with human genomics.

Authors:  Hao Wang; Qianglin Duan; Lemin Wang; Zhu Gong; Aibin Liang; Qiang Wang; Haoming Song; Fan Yang; Yanli Song
Journal:  Int J Med Sci       Date:  2012-07-11       Impact factor: 3.738

9.  Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting.

Authors:  Liam Smeeth; Claire Cook; Sara Thomas; Andrew J Hall; Richard Hubbard; Patrick Vallance
Journal:  Lancet       Date:  2006-04-01       Impact factor: 79.321

10.  Characteristics of the complement system gene expression deficiency in patients with symptomatic pulmonary embolism.

Authors:  Wei Lv; Lemin Wang; Qianglin Duan; Zhu Gong; Fan Yang; Haoming Song; Yanli Song
Journal:  Thromb Res       Date:  2013-05-30       Impact factor: 3.944

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.